Sodium Zirconium Cyclosilicate Generics bulk supplier for pharma manufacturers

Sodium Zirconium Cyclosilicate Generics 5g, 7g,10g sachets Suppliers & Bulk Manufacturers

Available Forms: Powder for oral suspension

Available Strengths: 5g, 7g,10g sachets

Reference Brands: Lokelma® (EU & US)

Sodium zirconium cyclosilicate (SZC) is an oral powder that binds potassium in the gut, used to treat high blood potassium (hyperkalaemia) in kidney disease and heart failure. It works within hours and is taken as a suspension in water. The originator product is Lokelma by AstraZeneca. Patent status differs by country, so we confirm what can lawfully be supplied to your destination before quoting.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Sodium Zirconium Cyclosilicate Generics? List it or send an offer →

Product Description:

Sodium Zirconium Cyclosilicate (SZC), marketed as Lokelma®, is a novel, highly selective potassium binder used to treat hyperkalemia in patients with chronic kidney disease, heart failure, or those on RAAS inhibitors. Approved by the FDA and EMA, it offers rapid onset and sustained potassium control with excellent tolerability. Available as a powder for oral suspension in 5 g and 10 g strengths, SZC is in high demand across EU and US pharmaceutical B2B markets. Ideal for licensing, distribution, and contract manufacturing partnerships, SZC represents a valuable addition to renal and cardiovascular therapeutic portfolios in regulated international markets.

Sodium Zirconium Cyclosilicate Generics — third party manufacturing & bulk supply

Sodium Zirconium Cyclosilicate Generics 5g, 7g,10g sachets is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Sodium Zirconium Cyclosilicate Generics is supplied as Powder for oral suspension — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Sodium Zirconium Cyclosilicate Generics listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Sodium Zirconium Cyclosilicate Generics →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Potassium begins to fall within an hour, so it can be used in acute hyperkalaemia as well as long-term. The starting dose is 10 g three times daily for up to 48 hours, then 5–10 g once daily.

Oedema, because each 5 g contains about 400 mg of sodium. Patients with heart failure are monitored.

Lokelma (AstraZeneca) is patented in the US and EU. Generic versions may be available in some markets, so we confirm the patent status for your destination.